The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Rho GTPase/Rho Kinase Inhibition as a Novel Target for the Treatment of Glaucoma
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase
Amano, M., Chihara, K., Kimura, K., Fukata, Y., Nakamura, N., Matsuura, Y., & Kaibuchi, K. (1997) · Science · doi:10.1126/science.275.5304.1308 · Cited by 1,077 · cited 1×
“ROCK2) affects actomyosin organization and generation of contractile force.[34,36,39,90-92] Rho kinase consists of three major do- Rho GTPase activity is regulated by physiological ligands and”
BackgroundHabas, R., Kato, Y., & He, X. (2001) · Cell · doi:10.1016/s0092-8674(01)00614-6 · Cited by 842 · cited 1×
“[64,65] The otrimeric GPCR, tyrosine kinase receptors, cytokine receptors, endogenous biosynthesis of isoprenoids, which are in (statins), frizzled receptors, and adhesion receptors[34,36,53,56] (figure 2).”
BackgroundLang, P., Gesbert, F., Delespine‐Carmagnat, M., Stancou, R., Pouchelet, M., & Bertoglio, J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00383.x · Cited by 558
Development of specific Rho-kinase inhibitors and their clinical application
Tamura, M., Nakao, H., Yoshizaki, H., Shiratsuchi, M., Shigyo, H., Yamada, H., Ozawa, T., Totsuka, J., & Hidaka, H. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.06.015 · Cited by 178 · cited 2×
“[29,33,70] To directly determine the demonstrated to induce very rapid and long-lasting decreases in influence of Rho GTPase activation on aqueous humor outflow, intraocular pressure (starting within 30 minutes of administration we expressed constitutively active RhoA GTPase in organ-cul- and lasting for over 6 to 12…”
Background
Cited by
Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension
Tanna, A. P., & Johnson, M. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2018.04.040 · Cited by 257
Mechanistic basis of Rho GTPase-induced extracellular matrix synthesis in trabecular meshwork cells
Pattabiraman, P. P., & Rao, P. V. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00317.2009 · Cited by 189
Metadata
- Authors
- Rao, V. P., & Epstein, D. L.
- Venue
- BioDrugs
- Published
- 2007
- Volume
- 21
- Issue
- 3
- Pages
- 167-177
- ISSN
- 1172-7039 (ISSN-L)
- 1173-8804
- OpenAlex
- W2017227447
- Cited by
- 184
- References
- 4
- FWCI
- 6.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rho GTPase/Rho Kinase Inhibition as a Novel Target for the Treatment of Glaucoma. https://app.cochat.ai/papers/10.2165/00063030-200721030-00004
- The paper
- Rao, V. P., & Epstein, D. L. (2007). Rho GTPase/Rho Kinase Inhibition as a Novel Target for the Treatment of Glaucoma. BioDrugs. https://doi.org/10.2165/00063030-200721030-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.